Premium
YB ‐1 promotes transcription of cyclin D1 in human non‐small‐cell lung cancers
Author(s) -
Harada Masanori,
Kotake Yojiro,
Ohhata Tatsuya,
Kitagawa Kyoko,
Niida Hiroyuki,
Matsuura Shun,
Funai Kazuhito,
Sugimura Haruhiko,
Suda Takafumi,
Kitagawa Masatoshi
Publication year - 2014
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/gtc.12150
Subject(s) - cyclin d1 , cyclin d , cancer research , biology , cyclin b , cyclin , cyclin a , lung cancer , carcinogenesis , cyclin a2 , cyclin e , microbiology and biotechnology , cell cycle , cancer , medicine , oncology , genetics
Cyclin D1, an oncogenic G1 cyclin, and YB‐1, a transcription factor involved in cell growth, are both over‐expressed in several human cancers. In human lung cancer, the functional association between YB‐1 and cyclin D1 has never been elucidated. In this study, we show YB‐1 is involved in the transcription of cyclin D1 in human lung cancer. Depletion of endogenous YB‐1 by siRNA inhibited progression of G1 phase and down‐regulated both the protein and mRNA levels of cyclin D1 in human lung cancer cells. Forced over‐expression of YB‐1 with a cyclin D1 reporter plasmid increased luciferase activity, and ChIP assay results showed YB‐1 bound to the cyclin D1 promoter. Moreover, the amount of YB‐1 mRNA positively correlated with cyclin D1 mRNA levels in clinical non‐small‐cell lung cancer (NSCLC) specimens. Immunohistochemical analysis also indicated YB‐1 expression correlated with cyclin D1 expression in NSCLC specimens. In addition, most of the cases expressing both cyclin D1 and CDC6, another molecule controlled by YB‐1, had co‐existing YB‐1 over‐expression. Together, our results suggest that aberrant expression of both cyclin D1 and CDC6 by YB‐1 over‐expression may collaboratively participate in lung carcinogenesis.